BRCA1 and obesity due to melanocortin 4 receptor deficiency: Thus, to improve clinical management of BRCA1 and BRCA2 mutation carriers is necessary a deep knowledge concerning the impact of modifiable factors, as obesity, on BC risk, that may provide the oncologists additional recommendations for the care of patients with BC.